David M Porterfield: the conversation
Mornings in the Lab · Center Stage · Interview transcript
Transcribed from the recorded guest conversation. Automatic transcription may contain errors. Timestamps refer to the source recording or segment.
[00:00:00] ↗[00:00:00] Maya: You've been in that meeting where the future gets treated like a cost center. A bold idea gets trimmed, then shelved, then somebody else builds the advantage you were too cautious to keep. In space, that kind of decision has a sharper edge. Food, oxygen, and biology become survival. And somehow, yes, this story runs straight through mushrooms and the moon.
[00:00:22] ↗[00:00:22] Maya: Dr. D. Marshall Porterfield goes by Marshall. His work circles one stubborn question: Can humans survive beyond Earth? At NASA, Marshall led space life and physical sciences, where life support wasn't theory. It was mission architecture. He originated Gene Lab, opening space biology data so researchers could study what life does when Earth is gone.
[00:00:43] ↗[00:00:43] Maya: Today, he still has one foot in the moon shot, leading NASA Leaf Science for Artemis III. But he also watched America cut bioregenerative life support programs built for deep space. China kept moving. The science America stepped away from is now part of China's lunar outpost strategy. A lot of people would've stopped at the warning.
[00:01:02] ↗[00:01:02] Maya: Marshall didn't. Back at Purdue, he turned survival engineering toward fungi. That became mycoponics, hydroponics for mushrooms, built for sterile, precision-controlled cultivation with pharmaceutical scale consequences. A Purdue lab, a lunar outpost. One question remains: Who's actually building survival beyond Earth?
[00:01:20] ↗[00:01:20] Maya: Marshall, welcome to the lab. We're very glad to have this conversation with you today.
[00:01:27] ↗[00:01:27] Keith: Hey, Johnny. Oh. Before... Hold on. Hey, John.
[00:01:29] ↗[00:01:29] Jon Andersen: Before he comes up. Yeah. Before he comes up. Did fucking Sophia turn Amish on us? What's up with the fucking dress?
[00:01:38] ↗[00:01:38] Keith: Hey, so get this, man. NASA spent years building the science to keep humans alive in deep space, and I know you're all about food and all this natural stuff. We're gonna have a great conversation today. The oxygen, the food, everything you would need for a real Martian scenario, and then, like we joke on this show, then they cut the whole program.
[00:01:56] ↗[00:01:56] Keith: You know who picked it up? The guys over there, China. Yeah, they're now the ones advancing the life support sciences that could decide who owns the moon, and the dude who's gonna talk about it with us, Dr. Marshall Porterfield. What's going on, Marshall?
[00:02:11] ↗[00:02:11] David M Porterfield: Wow, thanks for that great introduction, summary of what we're doing.
[00:02:15] ↗[00:02:15] Keith: Yeah.
[00:02:15] ↗[00:02:15] David M Porterfield: Thanks so much.
[00:02:16] ↗[00:02:16] Keith: Dude, we're- All right, doc ... excited to have you here today. Yeah
[00:02:22] ↗[00:02:22] David M Porterfield: Yeah, we're at a, critical time right now, and, we're, all anxiously seeing, you know, waiting to see how it's gonna unfold, how hi- how history is gonna, turn out.
[00:02:31] ↗[00:02:31] Keith: So
[00:02:31] ↗[00:02:31] David M Porterfield: what- You know, the Chine- Chinese have been planning this for a while.
[00:02:33] ↗[00:02:33] David M Porterfield: This is their 90th an- 80th anniversary of the, Cultural Revolution, so, you know, they've been s- they had that as a, a calendar point for 20 years, and they're gonna make their You know, in their party
[00:02:45] ↗[00:02:45] Keith: So, so Marshall, I
[00:02:46] ↗[00:02:46] Jon Andersen: gotta ask you- Let me, let me, I gotta ask a question first if you don't mind. Yeah. So Doc, if you could just by
[00:02:52] ↗[00:02:52] Jon Andersen: Pa- give us like a snapshot of what you think the next three decades will look like with this, just kind of one decade at a time. The next 10 years, B, A. The second 10 years, block B. Third 10, kind of give us a what, 'cause you've got a, a vision that none of us really can understand. give us an idea.
[00:03:12] ↗[00:03:12] David M Porterfield: Yeah. Well, you know, we're still dealing with our transportation and issues, building the, you know, the space flight architecture. But at the same time, we've been trying to build the, habitation architecture and the arc- architecture for really, to solve the logistics problem of humans in deep space.
[00:03:28] ↗[00:03:28] David M Porterfield: It really, it really ultimately comes down to what is the cost of resupply and can you produce what you need in, on site, in situ instead of,transporting everything? And that shift to bioregenerative systems, was really, has really been the main focus of, y- you know, the research I've been doing, throughout my entire career.
[00:03:49] ↗[00:03:49] David M Porterfield: Not just me, there's been a whole community of people that've been involved with the Controlled Ecological Life Support program at Kennedy Space Center that had led to the, the BioPlex program, which would've been the first closed human trials of a closed bioregenerative life support system. Wow. And it was supposed to be done at, a- at Johnson Space Flight Center, but that was, when that was canceled, those programs were canceled, those facilities were actually demolished.
[00:04:14] ↗[00:04:14] Keith: Wow. So Marshall, I got, I gotta, I gotta tell you, man. So Keith and John, and we do this show, you know, Monday through Friday here, we had some laughter a few weeks ago because while China's out there changing the world, all, my, all my friends at NASA and Artemis just busy flying by the moon. "Hey, we're flying by it.
[00:04:30] ↗[00:04:30] Keith: Hello." I'm like, "We're spending all this money just to fly by it?" So, so you as somebody who's trying to change the world as well, you must have watched that whole incident and go, "What the fuck are we doing just flying by saying hello?" seriously, Marshall.
[00:04:45] ↗[00:04:45] David M Porterfield: Well, I understood it in the context of the development of the rocket system.
[00:04:49] ↗[00:04:49] David M Porterfield: I went- Yeah ... there are certain s- you know, developmental steps you have to test out step by step. And if you go back to the history of even Gemini, where they were, testing docking of the capsules in space, just being able to dock, that allowed them to move on to the next technology,threshold that they had, that you need to, to buy down.
[00:05:08] ↗[00:05:08] David M Porterfield: And really, that was one other thing that Jared did when he came in, is he, reorganized Artemis and inserted a new mission, Artemis III, where they would actually test the human landing system before they would actually go to the moon. So we actually have- built into more of that architectural development into the, current, Artemis architecture.
[00:05:27] ↗[00:05:27] David M Porterfield: So that's, you know, that's the, that's our, transportation system. But we still need to buil- be able to develop the, the life support architecture so that we can, you know, deal with the waste we're gonna be producing there and, pro- and produce- You mean when, when you're taking a dump? ... the nutrients in the, in the food- So,
[00:05:46] ↗[00:05:46] Jon Andersen: so Doc, you're standing, there's no gravity.
[00:05:48] ↗[00:05:48] Jon Andersen: I can't just get up to take a dump and throw it off into, let it float away into space?
[00:05:52] ↗[00:05:52] David M Porterfield: No, there is gravity on the moon. There's one-sixth normal gravity, which is better than microgravity for, handling fluids and, you know, hydroponic systems. But it's, it's not enough gravity to actually, have normal,fluid systems like we have here on Earth.
[00:06:07] ↗[00:06:07] Jon Andersen: So, so if you literally were standing on the moon and you took a piss, what would happen to your pee? Where would it go? Oh,
[00:06:12] ↗[00:06:12] David M Porterfield: it would go down. Would
[00:06:13] ↗[00:06:13] Jon Andersen: it drift away or would it actually go towards your feet?
[00:06:16] ↗[00:06:16] David M Porterfield: it would go, it would go down towards your feet, but it would, probably some of the particles, the lighter stuff would tend to float up more.
[00:06:22] ↗[00:06:22] David M Porterfield: You'd get more aerosols.
[00:06:24] ↗[00:06:24] Keith: Oh,
[00:06:25] ↗[00:06:25] Jon Andersen: really?
[00:06:25] ↗[00:06:25] Keith: No shit. No shit. Hey, so, Marshall, Elon, recently, said, "Hey, this is gonna be awesome. Moon base, the lunar habitat." hey, Sterling Preston, let's play this clip for us to introduce us to our conversation with Marshall.
[00:06:37] ↗[00:06:37] Frankie and Tommy: We're going back to the moon, not a visit, a whole base.
[00:06:40] ↗[00:06:40] Frankie and Tommy: And Musk co-signed with nothing but American flag. NASA's building a permanent habitat at the Moon's South Pole. Real crew, science missions. It's the Mars pipeline. If
[00:06:50] ↗[00:06:50] Preston and Sterling: Musk's
[00:06:50] ↗[00:06:50] Frankie and Tommy: rockets are landing the crew, who really owns the base? That's the question nobody's asking loud enough.
[00:06:58] ↗[00:06:58] Keith: For comments on this?
[00:07:00] ↗[00:07:00] David M Porterfield: Well, that, that's a, that is a, a question of who is gonna build the moon base and how are we gonna build it.
[00:07:08] ↗[00:07:08] David M Porterfield: And part of that is actually, to, have a test bed where we can validate and test these technologies here on Earth before we actually have crew depending on these systems.
[00:07:18] ↗[00:07:18] Keith: Yeah.
[00:07:18] ↗[00:07:18] David M Porterfield: So we need actually a analog moon base here, and then build the copy on-
[00:07:24] ↗[00:07:24] Keith: Old, so where will they build it, where will they build it in America, Marshall?
[00:07:28] ↗[00:07:28] David M Porterfield: that we have, we don't know. That's one of the things. We don't know what that moon base plan is. We don't know what that architecture for the moon base is. There've been some plans in the past and some development in the past, but those are, you know, not necessarily were originally planning for full bioregenerative systems.
[00:07:45] ↗[00:07:45] Jon Andersen: Wow. So quick question, brother. As Aubrey's talking about the moon, why is, why is Elon Musk so interested in Mars?
[00:07:54] ↗[00:07:54] David M Porterfield: I think honestly, because it was the next big goal that everyone, you know, you know, f- a year ago, two years ago, everybody, you know, was thinking Mars, the next flag planting, right? but, you know, there's gonna be- there's still really serious, issues with space flight between Earth and Mars.
[00:08:10] ↗[00:08:10] David M Porterfield: There's still about a year, it would require for in transit for a crew in microgravity and deep space radiation, and that's just not feasible right now. Deep space radiation is outside of our, technology capability because of our, you know, lack of progress over the last 20 years on the ISS really.
[00:08:29] ↗[00:08:29] Jon Andersen: It was serious reality check- So let's assume, let's assume that somehow that was bypassed. Is there something about Mars itself that, that interests him more than doing the moon?
[00:08:39] ↗[00:08:39] David M Porterfield: I think, having a, a look, a second ho- a planetary home for humanity was really the other reason he is cited for, for, you know, his focus on Mars is really, it would be a second home for humanity and, Yeah, protecting humanity in case there's an asteroid hit the Earth, we'd have another planet that we were already, living on.
[00:08:59] ↗[00:08:59] David M Porterfield: I think that was really, part of that focus.
[00:09:01] ↗[00:09:01] Keith: But the real- but the reality, Marshall, you said, as, and it's funny because I was, I've been following this as well, is that the science has somewhat revealed itself that going there is really not technologically capable right now. So it's about resetting...
[00:09:14] ↗[00:09:14] Keith: Yeah, exactly, resetting the goals. Let's set it at mo- let's set it at the Moon while we continue to learn to go over here. But I gotta, I wa- I wanna, I wanna continue what brought you here, which is around mushrooms and mycoponics. And dude, you, you have said that bioregenerative life support programs like BLISS and CELSS, and I'd like you to talk about those with us, and that NASA cut those programs, but yet they're now the centerpiece of China's lunar outpost, and there's a race happening right now.
[00:09:42] ↗[00:09:42] Keith: Dude, that- that's a serious statement to say that we've cut it, and now they're doing it, and it's like nobody's really not doing much about it. So make it simple for Keith and Jon, a couple dummies over here. What did America actually give up, and is it too late to get it back?
[00:09:58] ↗[00:09:58] David M Porterfield: well, it's not too late. W- if we make the right investments now, we could actually...
[00:10:04] ↗[00:10:04] David M Porterfield: You know, we've proven in the past, in the 1960s, that we can do the impossible in a short period of time. If we remove the stops and we really focus on what those goals are, and we do it in a methodical way. And we know how to do it. We know how to- we did it once, and now we can go back and just really extend our ca- ability to stay there.
[00:10:23] ↗[00:10:23] David M Porterfield: And that really does involve activating these bioregenerative, technologies that have not been, s- fully supported and funded in the past by NASA because of, you know, they limited budget, and, competing priorities, commercializing low Earth orbit, and, you know, it's... Now we fa- actually have a mission.
[00:10:44] ↗[00:10:44] David M Porterfield: And, you know, even, even up until about six months ago, we didn't have this statement that we're gonna have build a moon base. Even about a year ago, it was really we're just gonna go back to the moon and go to- and then do a Mars mission. So they were already talking about pivoting to a Mars mission, but we really need to set up a habitat there and stay and learn how to live in deep space because that's our outpost in, beyond low Earth orbit, beyond the Van Allen belts.
[00:11:12] ↗[00:11:12] David M Porterfield: In that deep space radiation, we need to build habitats, shelters, learn about life in that radiation environment, but we're also moving, you know, moving outside of the Va- Van Allen belts for really the first time. If you go back and look at the Apollo missions, the 19 men who did those missions, those are the only individuals who've actually been in deep space Everyone else has been in within the Van Allen belts within lower Earth orbit on the ISS.
[00:11:38] ↗[00:11:38] John Petrocelli: Yeah.
[00:11:38] ↗[00:11:38] David M Porterfield: So they don't receive the same level of radiation. So if you look at the crew who spent six months on the ISS versus the crew who spent six days on average on, in Apollo, the Apollo crew had five to six times higher levels of cardiovascular disease and health, and poor out- health outcomes from that, from those missions.
[00:11:57] ↗[00:11:57] Keith: Really?
[00:11:58] ↗[00:11:58] David M Porterfield: Yeah.
[00:12:00] ↗[00:12:00] Keith: Wow. So I, I wanna go back. So biogenerative life support. So Marshall, that, simplifying that, that, that's essentially allowing us to eat food and live. Is that, am I... I, I'm really trying to simplify this. So is that what- Yeah ... what is biogenerative life support?
[00:12:14] ↗[00:12:14] David M Porterfield: We're part of an ecosystem here on Earth where plants, recycle the CO2 we breathe and produce oxygen.
[00:12:20] ↗[00:12:20] David M Porterfield: Yeah. They transpire water that can be recovered in pure form. So we can actually use plants as part of that re- as a bioregenerative recycling system to regenerate the atmosphere and also produce food. But then, you know, we've gotta look at the inedible portions of the plants, how to recycle that. On Earth, we do that with fungi and bacteria.
[00:12:42] ↗[00:12:42] video clip: Yeah.
[00:12:42] ↗[00:12:42] David M Porterfield: So that's why recycling systems are so important for regenerating the nutrients that you need for hydroponics.
[00:12:48] ↗[00:12:48] video clip: Yeah.
[00:12:48] ↗[00:12:48] David M Porterfield: But also too, fungi are producing critical nutrients, critical B vitamins that, are part of the ecosystem that we require for our diet, B vitamins for, that are really important for reactive oxygen species stress responses, which is really what we're gonna see in radiation.
[00:13:06] ↗[00:13:06] David M Porterfield: These are the vitamins that you need to protect you from radiation.
[00:13:10] ↗[00:13:10] Keith: A- and what you're basically saying is that all that technology and research shut down in America, picked up over in China, so in theory, that research and technology to allow humans to live, that research is gone. We don't have it anymore.
[00:13:25] ↗[00:13:25] David M Porterfield: Well, we don't, we don't have that capability. We haven't demonstrated that t- we basically built all that technology up with the cells program, and we canceled it right when we were getting ready to do the human trials. And then China was able just to pick that up, and when they completed it, they called it the Beijing Lunar Palace, and they were able to prove that they could keep a crew of four sustained for a year in a completely closed system.
[00:13:51] ↗[00:13:51] David M Porterfield: So now they, they've tested that on the ground. They know that they can do that on the ground. Now they're gonna try to do it in space.
[00:13:58] ↗[00:13:58] Keith: Wow. Wow. So mycoponics, break it down for Keith and Johnny simply. Has to do with mushrooms, fungi. Talk about it.
[00:14:09] ↗[00:14:09] David M Porterfield: Hydroponics for mushrooms. It's really the hydroponics growing, like growing plants without soil.
[00:14:15] ↗[00:14:15] David M Porterfield: That's really what we've done. We've been able to create an interface where we could grow mushrooms without soil or substrate. we use a liquid nutrient media, and we use a cer- ceramic, interface where we can provide the nutrients to. The fungi live on, in that interface, and they can grow and, produce, mushrooms and mycelium.
[00:14:34] ↗[00:14:34] David M Porterfield: Really we're looking at the mycelial products because that's where ... Turns out 18% of all of our pharmaceuticals come from fungal mycelial exudates. So this is actually a, a drug production platform c- and allows us to do continuous drug production. And, so we're not only gonna be p- producing food and important nutrition for the crew, we're gonna be able to have an astro pharmacy on, basically on the shelf with all the different mycelial lines.
[00:15:02] ↗[00:15:02] David M Porterfield: And when you need a particular drug for the crew members, you could take that out, activate it, grow it on the mycoponics, and then basically make tea or just take the exudate itself as the drug. We're producing lovastatin right now as a commercial pharmaceutical using mycoponics
[00:15:21] ↗[00:15:21] Keith: So Johnny, I, I, sorry to interrupt you.
[00:15:23] ↗[00:15:23] Keith: I've been intrigued by this. So are you saying like the, the mycoponics mushrooms are... I don't re-
[00:15:28] ↗[00:15:28] Jon Andersen: It sound, it sounds like some of these really high-tech weed growers.
[00:15:32] ↗[00:15:32] Keith: Yeah.
[00:15:33] ↗[00:15:33] Jon Andersen: You know, you do- don't they do that in, you know, like once it became legalized in certain places and all these guys and all their science shit, they-
[00:15:40] ↗[00:15:40] Keith: Yeah
[00:15:41] ↗[00:15:41] Jon Andersen: grow, they grow, don't they grow marijuana without soil too?
[00:15:45] ↗[00:15:45] Keith: Hydroponics, yeah.
[00:15:45] ↗[00:15:45] David M Porterfield: Oh, yeah, yeah. we, so actually that's what I worked on when I did my PhD. I worked on hydroponic technologies for, you know, space flight applications. But-
[00:15:55] ↗[00:15:55] Frankie and Tommy: Yeah ...
[00:15:55] ↗[00:15:55] David M Porterfield: a lot of that's been adopted by indoor growing community, for cannabis.
[00:16:00] ↗[00:16:00] David M Porterfield: Yeah ... we, we actually,developed the first LED lighting systems at that time for plants. Oh,
[00:16:05] ↗[00:16:05] Jon Andersen: really? You guys are, you guys are the, basically the reason that we've got this, this massive,
[00:16:10] ↗[00:16:10] David M Porterfield: That's the spinoff ... weed market. That's the spinoff, right? NASA's doing the difficult thing, trying to build a system to go to space, and in the process, we build technology, has application back here on Earth.
[00:16:21] ↗[00:16:21] David M Porterfield: Yeah. We spun off an entire, the, the entire controlled environment agriculture industry.
[00:16:26] ↗[00:16:26] Jon Andersen: Wow. That's crazy. Wow. So what- That's just a, just a little snippet of how when a new technology is put into play- Yeah ... it can be used any direction. It's, it's all about the user. How does he wanna use it for good or for bad?
[00:16:40] ↗[00:16:40] David M Porterfield: And so the, hydroponic technologies that we were developing then, working with, early, some of the early hydroponics w- with potatoes led to commercial cloning technology that they use today, where they create all the potato starts for, the potatoes that go in the field come from hydroponic technologies derived from NASA.
[00:16:59] ↗[00:16:59] Keith: Nope.
[00:16:59] ↗[00:16:59] David M Porterfield: So the, it, you know, your, so McDonald's every year they had their special potatoes.
[00:17:05] ↗[00:17:05] Keith: Yeah. Yeah.
[00:17:06] ↗[00:17:06] David M Porterfield: Yeah.
[00:17:06] ↗[00:17:06] Keith: Interesting.
[00:17:07] ↗[00:17:07] Jon Andersen: So
[00:17:07] ↗[00:17:07] Keith: back- I didn't
[00:17:08] ↗[00:17:08] Jon Andersen: know their french fries actually had potatoes in it.
[00:17:12] ↗[00:17:12] Keith: So back to mushrooms, Marshall. Is it, is it fair for me to say I'm, I'm gonna make a, a statement-
[00:17:17] ↗[00:17:17] Jon Andersen: Oh, what kind of mushrooms are we talking about?
[00:17:18] ↗[00:17:18] Jon Andersen: Mushrooms you put in an omelet or mushrooms you take to get fucked up?
[00:17:21] ↗[00:17:21] Keith: I think all kind of fungi is what I'm thinking about here. Like I'm just thinking so in terms, so Marshall- Food,
[00:17:26] ↗[00:17:26] David M Porterfield: pharma, and materials. We're actually growing mycelial leather.
[00:17:29] ↗[00:17:29] Keith: Yeah.
[00:17:29] ↗[00:17:29] David M Porterfield: So we've got a m- 3D myco-leather we're growing.
[00:17:32] ↗[00:17:32] David M Porterfield: We can grow-
[00:17:33] ↗[00:17:33] Keith: That's wild. Really?
[00:17:36] ↗[00:17:36] David M Porterfield: Wow.
[00:17:37] ↗[00:17:37] Keith: So mushrooms in some ways, I'm gonna, I'm gonna use, a, a word loaded in hyperbole, but, like a super plant, Marshall. the... It can do, very, very versatile.
[00:17:45] ↗[00:17:45] David M Porterfield: Yeah, if you let... really stop to think about everything that, that fungi do for us in our ecosystems as part of our life indirectly, let alone what we can, what we, what we built into, you know, technologies ex- derived from fungi.
[00:17:59] ↗[00:17:59] David M Porterfield: Like I said, 18% of our, our pharmaceuticals are FDA-approved pharmaceuticals come from fungi today.
[00:18:06] ↗[00:18:06] John Petrocelli: Really?
[00:18:06] ↗[00:18:06] Jon Andersen: Oh, yeah. That's interesting as hell.
[00:18:09] ↗[00:18:09] David M Porterfield: And they specifically come from the exudates from the mycelium, which is what we're producing with our mycoponic system s- essentially.
[00:18:19] ↗[00:18:19] Keith: So then Marshall, being a, being a fungi e-...
[00:18:21] ↗[00:18:21] Keith: Is it fungi or fungi? Apologies for... How, how, how, how is it, how is it said? Is it, is it-
[00:18:25] ↗[00:18:25] David M Porterfield: it depends on which, I guess, side of the pond you're on. I don't know which-
[00:18:29] ↗[00:18:29] Keith: I'm over here nor- oh, look at that. What is that?
[00:18:32] ↗[00:18:32] Jon Andersen: I was gonna say, he's leads leaning down to get something really cool for us to look at- Yeah, yeah
[00:18:35] ↗[00:18:35] Jon Andersen: is what I was thinking.
[00:18:36] ↗[00:18:36] David M Porterfield: What is that? This is, one of my, mycoponics tubes I, that I just keep in my office and play with.
[00:18:42] ↗[00:18:42] video clip: Of course.
[00:18:42] ↗[00:18:42] David M Porterfield: and this one's called mycelia. This is probably one of the oldest, c- cultivated, fungi To be in this, this form, growing in its final adult form, w- in terms of, cultivated, fungi.
[00:18:57] ↗[00:18:57] David M Porterfield: Usually, you know, with the bag culture or Petri dish culture, they only grow them for a few weeks or a month at the most, right? But this- What, what
[00:19:05] ↗[00:19:05] Jon Andersen: is it, what's in the top there? What the, what are you doing with one of
[00:19:06] ↗[00:19:06] David M Porterfield: these? That's a nutrient media. So we've developed a complete hy- mycoponic nutrient formula, just like a hydroponic complete nutrient media, like Hoagland and Arnon solution, but it's for mushrooms.
[00:19:17] ↗[00:19:17] David M Porterfield: So we're feeding that in, and this is the exudate system here. And, and it's really just dripping off the drugs into this fluid here.
[00:19:27] ↗[00:19:27] Keith: Dude, this is fucking cool, man. This is super cool. I'm nerd-ing out right now. This... So what would be a practical use of that other than, other than research? Or maybe there is nothing practical, Marshall, it's just more of a research thing.
[00:19:39] ↗[00:19:39] David M Porterfield: Drug manufacturing.
[00:19:41] ↗[00:19:41] Keith: Yeah, simple as that.
[00:19:42] ↗[00:19:42] David M Porterfield: Yeah, so just make bigger tubes, and then when they start creating these exudates, it's gonna be like a pharmaceutical waterfall.
[00:19:48] ↗[00:19:48] Keith: Really? So then you would-
[00:19:51] ↗[00:19:51] David M Porterfield: So we're actually scaling this up now to produce lovastatin.
[00:19:55] ↗[00:19:55] Keith: Wow. So then you, you, you, you would not be surprised then at, at the st- so as a fungi, fungi, fungi expert, you would not be surprised then at the state of the world o- on its acceptance with exer- psilocybins and, and, and magic mushrooms and so forth.
[00:20:09] ↗[00:20:09] Keith: you're probably sitting back, I'm thi- I'm making some assumptions here, going, "Finally, the fucking world caught up to everything I've known for a long time."
[00:20:17] ↗[00:20:17] David M Porterfield: yeah. It's, it seems Yeah, it's good momentum right now for our research.
[00:20:21] ↗[00:20:21] Keith: Yeah. Wow.
[00:20:24] ↗[00:20:24] David M Porterfield: Dude,
[00:20:24] ↗[00:20:24] Jon Andersen: this- I love, I love, real quick, I just gotta point out, when he's talking about the progress they're making- Yeah
[00:20:30] ↗[00:20:30] Jon Andersen: that was a very, very genuine smile. You see that? You can see the, the joy behind that. Yes. That's really cool, brother.
[00:20:36] ↗[00:20:36] Keith: Yeah, yeah. Well, here's a good place to go with then, Johnny. So there's a personal development angle to all this, Johnny, y- you know, that does not get talked enough about. so Marshall, you set audacious goals where those institutions cannot keep up with the vision.
[00:20:48] ↗[00:20:48] Keith: So, you know, you got all these big goals, institutions are cutting things that don't ha- you have no control over. How have you, Marshall Porterfield, personally managed that gap between where you know you, 'cause I can see your enthusiasm, that smile like Johnny called out. How do you manage the gap between where the science is going, where you wanna go, then there's funding, then there's policy, and there's public attention, and then all that conflict, Marshall?
[00:21:14] ↗[00:21:14] David M Porterfield: Yeah, no, it's, it's challenging, and it's also challenging to be in academia.
[00:21:18] ↗[00:21:18] Keith: Yes.
[00:21:19] ↗[00:21:19] David M Porterfield: And also dealing with intellectual property. You know, I've had some experiences in the past where I've written grants and, and the grant gets turned down and the, but yet that technology becomes commercialized somewhere else some- someday.
[00:21:32] ↗[00:21:32] David M Porterfield: Yeah.
[00:21:32] ↗[00:21:32] Keith: You
[00:21:33] ↗[00:21:33] David M Porterfield: know, my ideas. So I don't get permission to do it, but someone else takes the idea. and the peer review process. So that's why when I came up with the idea of Mycoponics, I didn't write any grants, and I really did it myself. I funded it myself.
[00:21:47] ↗[00:21:47] Preston and Sterling: Oh, wow.
[00:21:49] ↗[00:21:49] David M Porterfield: Yeah
[00:21:50] ↗[00:21:50] Jon Andersen: Wow.
[00:21:51] ↗[00:21:51] David M Porterfield: And that way I knew that m- I, once I got the intellectual property to the level that we could file it, I'd be able to file that and, with the goal of being able to have that commercial, process be able to endow my research in the future.
[00:22:04] ↗[00:22:04] Jon Andersen: Dude, that's- We're talking to a full-blown, true crusader here.
[00:22:08] ↗[00:22:08] Keith: We're talking to a savage, Johnny. Yes. You know what, Johnny, I love about this guy too is that we joke all the time, some- so Marshall, we joke on the show often, some guy has an idea, wants to start a business, first thing he does is he goes and spends a bunch of money getting lawyers rich by doing LLCs and getting everything set up, and then he never sells anything.
[00:22:24] ↗[00:22:24] Keith: They're go, "Oh, yeah, and I, I, oh yeah, I started my business but didn't do anything about it." Johnny, this guy here, he's "Fuck all the institutions. I'm gonna go spend some money and go and make something that nobody's- He's
[00:22:33] ↗[00:22:33] Jon Andersen: "I'm gonna, I'm gonna hide with this, and I'm gonna make sure that I get this thing before I reveal-
[00:22:38] ↗[00:22:38] Jon Andersen: the really cool shit that I just developed."
[00:22:40] ↗[00:22:40] Keith: I love him, man. This guy's a savage. Marshall Porterfield. Hey, Marshall, quest- quick question, I know we gotta get you out of here quickly here. A couple questions from the community if you, if you may. maybe you can answer this one, maybe you can't. Jess comes in and says, "How much psychology is necessary to remain in space?
[00:22:55] ↗[00:22:55] Keith: Life support is important, but can we mental ha- can we mentally handle it?" Marshall?
[00:22:59] ↗[00:22:59] David M Porterfield: Oh, yeah, that's a big part of, crew s- selection and training. Yeah. And it's also an interesting aspect of, the plant research we had done in the past, is that the crew who've worked with us on doing these experiments have always, been thankful that they've gotten that experience to work with the plants because getting that in space, it, it somehow really nurtures them and provides them with a connection back to Earth, back to something living.
[00:23:23] ↗[00:23:23] David M Porterfield: A lot of astronauts have you know, set up their own little plant growth experiments and,played around with plants in space. Yeah ... Scott Kelly and his one-year mission, he really, did a great job with growing the marigolds. Yeah. we had a problem with the watering system, and there was a little bit of like some mold growing.
[00:23:37] ↗[00:23:37] David M Porterfield: We was able to really take that over, and really it was because he nurtured the individual plants that he got, was able to get them to survive and, and flower. So really the, the plant aspect is gonna be something that's gonna be contributing to that, psychological support system for the crew, and that's really, you know, a big part of how we're looking at the whole integration of crew into an ecosystem because really it's, that's really way, we, we have to engineer these bioregenerative systems as from an ecosystems per- approach because we're, we, you know, we, on Earth we're part of this continuum where our gut is continuous with the soil and back.
[00:24:13] ↗[00:24:13] David M Porterfield: We need to make sure those connections are, there in space in these engineered systems.
[00:24:19] ↗[00:24:19] Keith: Fascinating stuff. Johnny, to wrap it up with, Marshall, any closing comments from Marshall? Johnny?
[00:24:23] ↗[00:24:23] Jon Andersen: I, honestly, brother, it was, it was great speaking with you, but more importantly, I wanna thank you for making what you're talking about understandable for- Those that don't have your knowledge base.
[00:24:33] ↗[00:24:33] Keith: Yeah, yeah. Well said, Jon. Yeah, 100%, Jonny. Marshall, it's so, so good to have you, brother. I hope you... So I, I, I'm suspecting you didn't know what you were walking into. You were in the green room and I saw you having some laughter with us, and on behalf of Jon and our entire community here, I wanna thank you as well, man.
[00:24:47] ↗[00:24:47] Keith: You made it simple, you made it understandable for us because- Yeah ... I, I know when I was, when I was nerding in, walking to the lab today, I saw my notes, I was like, "Ah." But, dude, you're awesome, man. I hope you'll come back sometime and hang out with us again.
[00:24:58] ↗[00:24:58] David M Porterfield: Yeah, sounds great, man. Thanks for that, compliment.
[00:25:00] ↗[00:25:00] David M Porterfield: That's a great compliment for an educator- ... because I, I'm always trying to make sure I can- ... you know, slow my brain down and change gear and, you know, talk
[00:25:10] ↗[00:25:10] Jon Andersen: to your, you know- Well, and brother, you, you, you did it beautifully, 'cause see, I'm, I'm the big dummy, so I'm the big dummy filter. If I understand it, everybody else is gonna understand it.
[00:25:19] ↗[00:25:19] Jon Andersen: So you did a great job.
[00:25:21] ↗[00:25:21] David M Porterfield: All right.
[00:25:23] ↗[00:25:23] Keith: So- There you go. So Marshall, your day is set. You can accomplish nothing for the rest of the day. You've made the big dummy understand what you had to say. That's perfect there, brother.
[00:25:32] ↗[00:25:32] Jon Andersen: Sounds good.